QTEX — QTREX Quantum Ltd.

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1837493 · Israel
Last close
$0.91
Market Cap
52W High
$3.85
52W Low
$0.28
ADV30
12,574,093
Next earnings
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 5,341,000 3,159,000 3,018,000
Dec 2024 8,070,000 5,111,000 3,748,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-79,794,000
Inventory
$735,000
Receivables
ST Investments
$0
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts
1

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 289,000 -13,623,000 -13,220,000 5,341,000 3,018,000 -9,861,000
Dec 2024 0 -11,267,000 -11,053,000 8,070,000 3,748,000 -9,374,000
Dec 2023 0 -12,133,000 -11,286,000 9,310,000 3,572,000 -9,691,000
Dec 2022 0 -14,893,000 -14,976,000 16,166,000 2,535,000 -9,209,000
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $122.06B $340.69
SYK STRYKER CORP $118.55B $309.24
MDT Medtronic plc $104.82B $81.89
MMM 3M CO $88.06B $170.76
BSX BOSTON SCIENTIFIC CORP $63.87B $42.97

News headlines (Yahoo Finance, 1h cache)

QTREX Quantum (QTEX) Files New Shelves, Is The Stock Already Overvalued?
2026-07-23 02:09 · Yahoo
QTREX Announces Clarification to Registration Statement on Form F-1
2026-07-22 16:40 · Yahoo
QTREX Appoints Dr. Shlomit Chappel-Ram, Veteran AME R&D Executive, as Independent Director
2026-07-17 12:30 · Yahoo
QTREX Secures Commercial Order and Begins Production for Leading International Government-Owned Company
2026-07-14 13:00 · Yahoo
QTREX Establishes U.S. Subsidiary to Advance Federal Government Contracting
2026-07-10 11:30 · Yahoo
QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security
2026-07-06 12:20 · Yahoo
QTREX Engineers Conductivity Itself to Address Quantum Computing’s Cryogenic Heat-Load Barrier
2026-07-01 12:40 · Yahoo
QTREX Quantum (QTEX) Produces Cryogenic Chip Carrier Using Proprietary AME Process
2026-06-28 09:34 · Yahoo
QTREX Announces Management Share Purchase Plan
2026-06-22 11:00 · Yahoo
QTREX Expands into Quantum Processor Interface with Single-Build Cryogenic Chip Carrier
2026-06-18 11:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.